Nursing and Internal Medicine Partnership in the Long-Term Management of Chronic Obstructive Pulmonary Disease
DOI:
https://doi.org/10.22399/ijcesen.4286Keywords:
Nursing, Internal Medicine, Chronic Obstructive Pulmonary Disease, COPD, Long-Term ManagementAbstract
The partnership between nursing and internal medicine is crucial for the effective long-term management of Chronic Obstructive Pulmonary Disease (COPD). With the growing prevalence of COPD, a multifaceted approach that combines the clinical expertise of internal medicine professionals with the compassionate care delivered by nursing staff is essential. Nurses play a vital role in patient education, teaching individuals about medication adherence, lifestyle modifications, and self-management strategies. By empowering patients with knowledge and skills, nurses help improve adherence to treatment plans, reduce hospitalizations, and enhance overall quality of life for those living with COPD. This collaborative model ensures that patients receive holistic care that addresses both their physical and emotional needs. In addition to patient education, the nursing-internal medicine partnership enhances the monitoring and assessment of COPD patients. Regular follow-ups and evaluations conducted by nurses can identify exacerbations early, enabling timely interventions by internal medicine physicians. This proactive approach not only prevents complications and hospital readmissions but also reallocates healthcare resources efficiently. Moreover, the integration of technology, such as telehealth and remote monitoring tools, allows for continuous communication and support between patients and their healthcare team. By working together, nurses and internal medicine specialists can implement evidence-based practices and create personalized care plans that cater to the unique needs of each COPD patient, ultimately leading to better health outcomes.
References
1. Aboumatar H, Naqibuddin M, Chung S, et al. Effect of a hospital-initiated program combining transitional care and long-term self-management support on outcomes of patients hospitalized with chronic obstructive pulmonary disease: a randomized clinical trial. JAMA. 2019;322(14):1371-1380.
2. Adeloye D, Song P, Zhu Y, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10:447-458.
3. Ahn JH, Chung JH, Shin KC, et al. Critical inhaler handling error is an independent risk factor for frequent exacerbations of chronic obstructive pulmonary disease: interim results of a single center prospective study. Int J Chron Obstruct Pulmon Dis. 2019;14:2767-2775.
4. Aranburu-Imatz A, López-Carrasco JC, Moreno-Luque A, et al. Nurse-led interventions in chronic obstructive pulmonary disease patients: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19:9101.
5. Arruda H, Silva ER, Lessa M, et al. VOSviewer and Bibliometrix. J Med Libr Assoc. 2022;110:392-395.
6. Barr RG, Herbstman J, Speizer FE, et al. Validation of self-reported chronic obstructive pulmonary disease in a cohort study of nurses. Am J Epidemiol. 2002;155:965-971.
7. Bourbeau J, Julien M, Maltais F, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med. 2003;163:585-591.
8. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370:741-750.
9. Calzetta L, Pistocchini E, Chetta A, et al. Experimental drugs in clinical trials for COPD: artificial intelligence via machine learning approach to predict the successful advance from early-stage development to approval. Expert Opin Investig Drugs. 2023;32:525-536.
10. Casas A, Troosters T, Garcia-Aymerich J, et al. Integrated care prevents hospitalisations for exacerbations in COPD patients. Eur Respir J. 2006;28(1):123-130.
11. Chen J, Weldemichael L, Zeng S, et al. Actigraphy informs distinct patient-centered outcomes in Pre-COPD. Respir Med. 2021;187:106543.
12. Chevrolet JC, Jolliet P, Abajo B, et al. Nasal positive pressure ventilation in patients with acute respiratory failure: difficult and time-consuming procedure for nurses. Chest. 1991;100:775-782.
13. Confalonieri M, Potena A, Carbone G, Porta RD, Tolley EA, Umberto Meduri G. Acute respiratory failure in patients with severe community-acquired pneumonia: a prospective randomized evaluation of noninvasive ventilation. Am J Respir Crit Care Med. 1999;160(5 Pt 1):1585-1591.
14. Coultas D, Frederick J, Barnett B, Singh G, Wludyka P. A randomized trial of two types of nurse-assisted home care for patients with COPD. Chest. 2005;128(4):2017-2024.
15. Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg. 1993;56(3):539-549.
16. Eaton T, Withy S, Garrett JE, Mercer J, Whitlock RM, Rea HH. Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. Chest. 1999;116(2):416-423.
17. Estabrooks CA, Midodzi WK, Cummings GG, Ricker KL, Giovannetti P. The impact of hospital nursing characteristics on 30-day mortality. Nurs Res. 2005;54(2):74-84.
18. Fazleen A, Wilkinson T. Early COPD: current evidence for diagnosis and management. Ther Adv Respir Dis. 2020;14:1753466620942128.
19. Fraser DD, Kee CC, Minick P. Living with chronic obstructive pulmonary disease: insiders' perspectives. J Adv Nurs. 2006;55(5):550-558.
20. GBD 2021 Demographics Collaborators. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:1989-2056.
21. Gioia F, Walti LN, Orchanian-Cheff A, et al. Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis. Lancet Respir Med. 2024;12:207-216.
22. Haggerty MC, Stockdale-Woolley R, Nair S. Respi-Care: an innovative home care program for the patient with chronic obstructive pulmonary disease. Chest. 1991;100(3):607-612.
23. Halpin DMG, Criner GJ, Papi A, et al. The 2020 GOLD science committee report on COVID-19 and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2021;203:24-36.
24. Helvaci A, Gok Metin Z. The effects of nurse-driven self-management programs on chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Adv Nurs. 2020;76:2849-2871.
25. Johnson KM, Khakban A, Bryan S, et al. Healthcare system encounters before COPD diagnosis: a registry-based longitudinal cohort study. Thorax. 2020;75:108-115.
26. Jonsdottir H, Amundadottir OR, Gudmundsson G, et al. Effectiveness of a partnership-based self-management programme for patients with mild and moderate chronic obstructive pulmonary disease: a pragmatic randomized controlled trial. J Adv Nurs. 2015;71(11):2634-2649.
27. Kim HY, Lee HS, Kim IH, et al. Comprehensive targeted metabolomic study in the lung, plasma, and urine of PPE/LPS-induced COPD mice model. Int J Mol Sci. 2022;23:2748.
28. Kramer N, Meyer TJ, Meharg J, Cece RD, Hill NS. Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med. 1995;151(6):1799-1806.
29. Lareau SC, Fahy B, Meek P, et al. Chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med. 2019;199:P1-P2.
30. Loh CH, Peters SP, Lovings TM, et al. Suboptimal inspiratory flow rates are associated with chronic obstructive pulmonary disease and all-cause readmissions. Ann Am Thorac Soc. 2017;14:1305-1311.
31. McLean S, Hoogendoorn M, Hoogenveen RT, et al. Projecting the COPD population and costs in England and Scotland: 2011 to 2030. Sci Rep. 2016;6:31893.
32. Monninkhof E, van der Valk P, van der Palen J, van Herwaarden C, Partridge MR, Zielhuis G. Self-management education for patients with chronic obstructive pulmonary disease: a systematic review. Thorax. 2003;58(5):394-398.
33. Nava S, Evangelisti I, Rampulla C, et al. Human and financial costs of noninvasive mechanical ventilation in patients affected by COPD and acute respiratory failure. Chest. 1997;111:1631-1638.
34. Özçam M, Lynch SV. The gut-airway microbiome axis in health and respiratory diseases. Nat Rev Microbiol. 2024;22:492-506.
35. Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185:435-452.
36. Rabe KF. Treating COPD--the TORCH trial, P values, and the Dodo. N Engl J Med. 2007;356(8):851-854.
37. Rea H, McAuley S, Stewart A, Lamont C, Roseman P, Didsbury P. A chronic disease management programme can reduce days in hospital for patients with chronic obstructive pulmonary disease. Intern Med J. 2004;34(11):608-614.
38. Rice VH, Heath L, Livingstone-Banks J, et al. Nursing interventions for smoking cessation. Cochrane Database Syst Rev. 2017;12:CD001188.
39. Safiri S, Carson-Chahhoud K, Noori M, et al. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019. BMJ. 2022;378:e069679.
40. Simons SO, Hurst JR, Miravitlles M, et al. Caring for patients with COPD and COVID-19: a viewpoint to spark discussion. Thorax. 2020;75:1035-1039.
41. Steen S, Sjöberg T, Pierre L, Liao Q, Eriksson L, Algotsson L. Transplantation of lungs from a non-heart-beating donor. Lancet. 2001;357(9259):825-829.
42. Teno JM, Gozalo PL, Bynum JP, et al. Change in end-of-life care for Medicare beneficiaries: site of death, place of care, and health care transitions in 2000, 2005, and 2009. JAMA. 2013;309(5):470-477.
43. Vermeersch K, Gabrovska M, Aumann J, et al. Azithromycin during acute chronic obstructive pulmonary disease exacerbations requiring hospitalization (BACE). A multicenter, randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med. 2019;200:857-868.
44. Volpato S, Cavalieri M, Sioulis F, et al. Predictive value of the short physical performance battery following hospitalization in older patients. J Gerontol A Biol Sci Med Sci. 2011;66(1):89-96.
45. Wan Y, Shen J, Ouyang J, et al. Bibliometric and visual analysis of neutrophil extracellular traps from 2004 to 2022. Front Immunol. 2022;13:1025861.
46. Weinberger M, Hendeles L. Theophylline in asthma. N Engl J Med. 1996;334(21):1380-1388.
47. Wong KW, Wong FK, Chan MF. Effects of nurse-initiated telephone follow-up on self-efficacy among patients with chronic obstructive pulmonary disease. J Adv Nurs. 2005;49(2):210-222.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 International Journal of Computational and Experimental Science and Engineering
This work is licensed under a Creative Commons Attribution 4.0 International License.
